Acta Pharmaceutica Sinica B Q1 Unclaimed
Acta Pharmaceutica Sinica B is a journal indexed in SJR in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) with an H index of 99. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system The scope of the journal is focused on pharmaceutical science, traditional Chinese medicine, pharmaceutics, pharmaceutical chemistry, pharmacokinetics. It has an SJR impact factor of 3,035 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,035.
Type: Journal
Type of Copyright: CC BY-NC-ND
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
3,035
SJR Impact factor99
H Index327
Total Docs (Last Year)748
Total Docs (3 years)27863
Total Refs10510
Total Cites (3 years)710
Citable Docs (3 years)14.09
Cites/Doc (2 years)85.21
Ref/DocOther journals with similar parameters
Theranostics Q1
Clinical Cancer Drugs Q1
PLoS Neglected Tropical Diseases Q1
Life Sciences Q1
American Journal of Pharmaceutical Education Q1
Compare this journals
Aims and Scope
Best articles by citations
2,3-Diaryl-3 H -imidazo[4,5- b ]pyridine derivatives as potential anticancer and anti-inflammatory agents
View moreSite-specific PEGylation of lidamycin and its antitumor activity
View moreCombinatorial mutation on the beta-glycosidase specific to 7-beta-xylosyltaxanes and increasing the mutated enzyme production by engineering the recombinant yeast
View moreIn situ monitoring of the structural change of microemulsions in simulated gastrointestinal conditions by SAXS and FRET
View moreTaxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
View moreInteractions among SARS-CoV accessory proteins revealed by bimolecular fluorescence complementation assay
View moreTargeting peptide-decorated biomimetic lipoproteins improve deep penetration and cancer cells accessibility in solid tumor
View moreCloning and analysis of 1-hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate reductase genes HsHDR1 and HsHDR2 in Huperzia serrate
View moreDevelopment and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability
View moreEffects and mechanisms of berberine in diabetes treatment
View moreHigh degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care
View moreIdentification of anti-Gram-negative bacteria agents targeting the interaction between ribosomal proteins L12 and L10
View moreTherapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity
View moreA new sesquiterpene lactone and a new aromatic glycoside from Illicium difengpi
View moreNovel N-(pyrimidin-4-yl)thiazol-2-amine derivatives as dual-action hypoglycemic agents that activate GK and PPAR gamma
View moreProtective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions
View moreEffects of antibiotic antitumor drugs on nucleotide levels in cultured tumor cells: an exploratory method to distinguish the mechanisms of antitumor drug action based on targeted metabolomics
View moreDevelopment of a new ferulic acid certified reference material for use in clinical chemistry and pharmaceutical analysis
View moreNoncoding microRNAs: small RNAs play a big role in regulation of ADME?
View moreCdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunity
View morePreliminary investigations into surface molecularly imprinted nanoparticles for Helicobacter pylori eradication
View moreCurrent developments in pharmacological therapeutics for chronic constipation
View more3D tissue engineering, an emerging technique for pharmaceutical research
View moreAcetylenes and fatty acids from Codonopsis pilosula
View more
Comments